药易购
(300937)
| 流通市值：15.94亿 | | | 总市值：23.51亿 |
| 流通股本：6486.42万 | | | 总股本：9566.67万 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,180,537,149.98 | 1,113,920,597 | 4,454,001,549.38 | 3,242,124,750.68 |
| 营业收入 | 2,180,537,149.98 | 1,113,920,597 | 4,454,001,549.38 | 3,242,124,750.68 |
| 二、营业总成本 | 2,180,778,585.96 | 1,099,524,353.69 | 4,421,142,447.4 | 3,215,835,561.02 |
| 营业成本 | 1,980,583,582.61 | 1,000,838,700.95 | 3,990,093,739.33 | 2,884,224,490.97 |
| 税金及附加 | 3,887,856.14 | 1,979,446.63 | 9,266,603.29 | 6,427,720.7 |
| 销售费用 | 148,052,933.56 | 73,889,959.27 | 324,125,373.26 | 257,750,651.18 |
| 管理费用 | 37,391,037.02 | 18,376,677.49 | 77,661,535.76 | 52,007,950.24 |
| 研发费用 | 6,295,049.06 | 2,518,249.71 | 10,721,084.94 | 8,177,056.7 |
| 财务费用 | 4,568,127.57 | 1,921,319.64 | 9,274,110.82 | 7,247,691.23 |
| 其中:利息费用 | 3,608,170.81 | 1,870,410.63 | - | 6,245,323.06 |
| 其中:利息收入 | 1,786,291.84 | 366,111.74 | - | 2,605,554.65 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | - | 0 | - |
| 加:投资收益 | 1,882,557.67 | 384,125.54 | -363,423.74 | 937,267.79 |
| 汇兑收益 | - | - | 0 | - |
| 资产处置收益 | -14,694.39 | -2,770.27 | -9,311.77 | 162,165.11 |
| 资产减值损失(新) | -1,057,145.8 | -509,664.61 | -9,913,533.42 | -6,710,869.07 |
| 信用减值损失(新) | -15,545,200.75 | -11,717,520.22 | -15,766,038.85 | -18,085,506.5 |
| 其他收益 | 3,183,984.26 | 293,356.09 | 2,113,891.93 | 1,430,965.05 |
| 四、营业利润 | -11,791,934.99 | 2,843,769.84 | 8,920,686.13 | 4,023,212.04 |
| 加:营业外收入 | 212,242.29 | 53,285.75 | 789,269.34 | 224,117.9 |
| 减:营业外支出 | 1,228,620.63 | 74,607.16 | 2,532,628.35 | 662,435.98 |
| 五、利润总额 | -12,808,313.33 | 2,822,448.43 | 7,177,327.12 | 3,584,893.96 |
| 减:所得税费用 | 1,036,148.43 | 1,638,836.28 | 23,633,056.91 | 11,790,037.47 |
| 六、净利润 | -13,844,461.76 | 1,183,612.15 | -16,455,729.79 | -8,205,143.51 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -13,844,461.76 | 1,183,612.15 | -16,455,729.79 | -8,205,143.51 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -9,526,837.11 | -2,720,169.6 | -12,851,490.08 | -8,356,461.16 |
| 少数股东损益 | -4,317,624.65 | 3,903,781.75 | -3,604,239.71 | 151,317.65 |
| 扣除非经常损益后的净利润 | -10,584,461.03 | -3,084,111.65 | -14,302,015.24 | -10,152,605.74 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.1 | -0.03 | -0.13 | -0.09 |
| (二)稀释每股收益 | -0.1 | -0.03 | -0.13 | -0.09 |
| 九、综合收益总额 | -13,844,461.76 | 1,183,612.15 | -16,455,729.79 | -8,205,143.51 |
| 归属于母公司股东的综合收益总额 | -9,526,837.11 | -2,720,169.6 | -12,851,490.08 | -8,356,461.16 |
| 归属于少数股东的综合收益总额 | -4,317,624.65 | 3,903,781.75 | -3,604,239.71 | 151,317.65 |
| 公告日期 | 2026-08-25 | 2026-04-29 | 2026-04-29 | 2025-10-24 |
| 审计意见(境内) | | | 保留意见 | |